|
1
|
DiSalvo AF, Fickling AM and Ajello L:
Infection caused by Penicillium marneffei: Description of first
natural infection in man. Am J Clin Pathol. 60:259–263. 1973.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vanittanakom N, Cooper CR Jr, Fisher MC
and Sirisanthana T: Penicillium marneffei infection and recent
advances in the epidemiology and molecular biology aspects. Clin
Microbiol Rev. 19:95–110. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ustianowski AP, Sieu TP and Day JN:
Penicillium marneffei Infection in HIV. Curr Opin Infect Dis.
21:31–36. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Supparatpinyo K, Khamwan C, Baosoung V,
Nelson KE and Sirisanthana T: Disseminated Penicillium marneffei
infection in Southeast Asia. Lancet. 344:110–113. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kawila R, Chaiwarith R and Supparatpinyo
K: Clinical and laboratory characteristics of penicilliosis
marneffei among patients with and without HIV infection in northern
Thailand: A retrospective study. BMC Infect Dis. 13:4642013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zheng J, Gui X, Cao Q, Yang R, Yan Y, Deng
L and Lio J: A clinical study of acquired immunodeficiency syndrome
associated Penicillium mameffei infection from a non-endemic area
in China. PLOS One. 10:e01303762015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Le T, Hong Chau TT, Kim Cuc NT, Si Lam P,
Manh Sieu TP, Shikuma CM and Day JN: AIDS-Associated Cryptococcus
neoformans and Penicillium marneffei Coinfection: A therapeutic
dilemma in resource-limited settings. Clin Infect Dis. 51:e65–e68.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Larsson M, Nguyen LH, Wertheim HF, Dao TT,
Taylor W, Horby P, Nguyen TV, Nguyen MH, Le T and Nguyen KV:
Clinical characteristics and outcome of Penicillium mameffei
infection among HIV-infected patients in northern Vietnam. AIDS Res
Ther. 9:242012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hatakeyama S, Yamashita T, Sakai T and
Kamei K: Case Report: Disseminated Talaromyces (Penicillium)
marneffei and mycobacterium tuberculosis coinfection in
a japanese patient with acquired immunodeficiency syndrome. Am J
Trop Med Hyg. 97:38–41. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nascimento E, Vitali LH, Kress MRVZ and
Martinez R: Cryptococcus neoformans and C. Gattii isolates from
both HIV-infected and uninfected patients: Antifungal
susceptibility and outcome of cryptococcal disease. Rev Inst Med
Trop Sao Paulo. 59:e492017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin JN, Lin HH, Lai CH, Wang JL and Yu TJ:
Renal transplant recipient infected with Penicillium marneffei.
Lancet Infect Dis. 10:1382010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chong YB, Tan LP, Robinson S, Lim SK, Ng
KP, Keng TC and Kamarulzaman A: Penicilliosis in lupus patients
presenting with unresolved fever: A report of 2 cases and
literature review. Trop Biomed. 29:270–276. 2012.PubMed/NCBI
|
|
13
|
Lee PP, Chan KW, Lee TL, Ho MH, Chen XY,
Li CH, Chu KM, Zeng HS and Lau YL: Penicilliosis in children
without HIV infection-are they immunodeficient? Clin Infect Dis.
54:e8–e19. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chitasombat M and Supparatpinyo K:
Penicillium marneffei infection in immunocompromised host.
Curr Fungal Infect Rep. 7:44–50. 2013. View Article : Google Scholar
|
|
15
|
Wong SY and Wong KF: Penicillium mameffei
infection in AIDS. Pathol Res Int. 2011:7642932011. View Article : Google Scholar
|
|
16
|
Ma T, Chen R, Li X, Lu C and Xi L: The in
vitro fungicidal activity of human macrophages against Penicillium
marneffei is suppressed by dexamethasone. Microb Pathog. 86:26–31.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Browne SK, Burbelo PD, Chetchotisakd P,
Suputtamongkol Y, Kiertiburanakul S, Shaw PA, Kirk JL, Jutivorakool
K, Zaman R, Ding L, et al: Adult-onset immunodeficiency in thailand
and taiwan. N Engl J Med. 367:725–734. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee PP, Mao H, Yang W, Chan KW, Ho MH, Lee
TL, Chan JF, Woo PC, Tu W and Lau YL: Penicillium marneffei
infection and impaired IFN-γ immunity in humans with
autosomal-dominant gain-of-phosphorylation STAT1 mutations. J
Allergy Clin Immunol. 133:894–896.e5. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vanittanakom N and Sirisanthana T:
Penicillium marneffei infection in patients infected with human
immunodeficiency virus. Curr Top Med Mycol. 8:35–42.
1997.PubMed/NCBI
|
|
20
|
Sirisanthana T, Supparatpinyo K, Perriens
J and Nelson KE: Amphotericin B and itraconazole for treatment of
disseminated Penicillium marneffei infection in human
immunodeficiency virus-infected patients. Clin Infect Dis.
26:1107–1110. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang JL, Hung CC, Chang SC, Chueh SC and
La MK: Disseminated Penicillium marneffei infection in a
renal-transplant recipient successfully treated with liposomal
amphotericin B. Transplantation. 76:1136–1137. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Walsh TJ, Pappas P, Winston DJ, Lazarus
HM, Petersen F, Raffalli J, Yanovich S, Stiff P, Greenberg R,
Donowitz G, et al: Voriconazole compared with liposomal
amphotericin B for empirical antifungal therapy in patients with
neutropenia and persistent fever. N Engl J Med. 346:225–234. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zmeili OS and Soubani AO: Pulmonary
aspergillosis: A clinical update. QJM. 100:317–334. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ouyang Y, Cai S, Liang H and Cao C:
Administration of voriconazole in disseminated talaromyces
(Penicillium) Marneffei Infection: A Retrospective Study.
Mycopathologia. 182:569–575. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Perfect JR, Marr KA, Walsh TJ, Greenberg
RN, DuPont B, de la Torre-Cisneros J, Just-Nübling G, Schlamm HT,
Lutsar I, Espinel-Ingroff A and Johnson E: Voriconazole treatment
for less-common, emerging, or refractory fungal infections. Clin
Infect Dis. 36:1122–1131. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Alves IA, Staudt KJ, Silva CM, Lock GA,
Dalla Costa T and de Araujo BV: Influence of experimental
cryptococcal meningitis in wistar rats on voriconazole brain
penetration assessed by microdialysis. Antimicrob Agents Chemother.
61(pii): e00321–e00417. 2017.PubMed/NCBI
|
|
27
|
Herkert PF, Hagen F, de Oliveira Salvador
GL, Gomes RR, Ferreira MS, Vicente VA, Muro MD, Pinheiro RL, Meis
JF and Queiroz-Telles F: Molecular characterisation and antifungal
susceptibility of clinical Cryptococcus deuterogattii (AFLP6/VGII)
isolates from Southern Brazil. Eur J Clin Microbiol Infect Dis.
35:1803–1810. 2016. View Article : Google Scholar : PubMed/NCBI
|
